Hot stocks: Brokerage view on L&T Finance, IndiGo and Zydus Lifesciences

Axis Capital has downgraded IndiGo from a buy rating to an add rating, though it has raised the target price to Rs 5,100 from Rs 4,700. The downgrade reflects limited upside potential, with Axis Capital highlighting supply-side issues and noting that further improvement may be constrained as load factors are already at an optimal level of 80%.